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Background: Articular cartilage has poor intrinsic capacity for regeneration because of its avascularity and very
slow cellular turnover. Defects deriving from trauma or joint disease tend to be repaired with fibrocartilage rather
than hyaline cartilage. Consequent degenerative processes are related to the width and depth of the defect. Since
mesenchymal stem cells (MSCs) deriving from patients affected by osteoarthritis have a lower proliferative and
chondrogenic activity, the systemic or local delivery of heterologous cells may enhance regeneration or inhibit the
progressive loss of joint tissue. Embryonic stem cells (ESCs) are very promising, since they can self-renew for
prolonged periods without differentiation and can differentiate into tissues from all the 3 germ layers. To date only
a few experiments have used ESCs for the study of the cartilage regeneration in animal models and most of them
used laboratory animals. Sheep, due to their anatomical, physiological and immunological similarity to humans,
represent a valid model for translational studies. This experiment aimed to evaluate if the local delivery of male
sheep embryonic stem-like (ES-like) cells into osteochondral defects in the femoral condyles of adult sheep can
enhance the regeneration of articular cartilage. Twenty-two ewes were divided into 5 groups (1, 2, 6, 12 and
24 months after surgery). Newly formed tissue was evaluated by macroscopic, histological, immunohistochemical
(collagen type II) and fluorescent in situ hybridization (FISH) assays.
Results: Regenerated tissue was ultimately evaluated on 17 sheep. Samples engrafted with ES-like cells had
significantly better histologic evidence of regeneration with respect to empty defects, used as controls, at all time
periods.
Conclusions: Histological assessments demonstrated that the local delivery of ES-like cells into osteochondral
defects in sheep femoral condyles enhances the regeneration of the articular hyaline cartilage, without signs of
immune rejection or teratoma for 24 months after engraftment.
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SheepBackground
Articular cartilage has a poor intrinsic capacity for re-
generation because of its avascularity and very slow
turnover both at the cellular and molecular levels. As
consequence, defects occurring as a result of trauma or
joint disease tend to be repaired with fibrocartilage ra-
ther than hyaline cartilage. With time, degenerative pro-
cesses frequently occur in the regenerated tissue [1-3],
which may stabilize or progress in relation to 2 main* Correspondence: rocca@uniss.it
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unless otherwise stated.factors: the width and depth of the defect. It has been
demonstrated that sheep articular cartilage osteochondral
defects 3 mm wide or less re-fill with normal hyaline car-
tilage, whereas wider defects are replaced by fibrocartilage
which, eventually, degenerates into fibrous tissue [4]. This
inferior regenerated tissue is not capable of withstanding
the mechanical loads exerted on the tissue during locomo-
tion and the result is eburnation of the subchondral bone
[4,5]. In relation to the depth, superficial defects involv-
ing only the articular cartilage do not heal spontan-
eously [1,2,6], while osteochondral defects, penetrating
the subchondral bone and thus, gaining access to thehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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marrow space, can give rise to regenerated cartilage [7-9].
Surgical treatments used to stimulate cartilage regen-
eration, in most cases, result only in a delay in the onset
of degenerative processes [10-15]. Thus, there is a search
for alternative solutions, and cell engraftment is among
the most advanced new technologies in cartilage regen-
eration [16-19]. Considering that in certain degenerative
diseases, autologous stem cells are depleted and have
reduced proliferative capacity and chondrogenic ability
[20,21], the delivery of heterologous cells may enhance
regeneration or inhibit the progressive loss of joint tis-
sue [20,21]. Among the several factors to be considered
in the choice of the type of cells, there are the ease of
harvest, the cell yield and purity and their proliferative
and chondrogenic capacity [22]. Autologous chondro-
cyte implantation (ACI), the first technique used to
repair focal cartilage defects [23-25], is associated with
donor site morbidity, loss of chondrocyte phenotype upon
ex vivo expansion and inferior fibrocartilage formation at
the defect site [26-28]. Thus, new extracorporeal cell sour-
ces are sought, mainly stem cells. Among them, MSCs
[17,18,21,29,30] have the advantages of their immunoeva-
sivity [31] and immunosuppressive effect [32,33], but they
have a limited capacity for self-renewal and proliferation,
and differentiation potential decreases with increasing
donor age [34]. On the contrary, embryonic stem cells
(ESCs) are able to self-renew for prolonged periods with-
out differentiation and, most importantly, to differentiate
into a large variety of tissues derived from all 3 germ
layers [35-38]. Despite the fact that their use is compli-
cated by immunologic incompatibility and possible devel-
opment of teratomas [39-41], as well as the existence of
ethical problems in human application, in the future, the
establishment of ESCs lines from ungulates could allow
their employment in bulk for basic research and for pro-
ducing animal models of human diseases [42]. Indeed, the
histological appearance of the articular regenerated tissue
is essential for the validation of therapeutic interventions
[9] and it is likely to be predictive of its functionality and
durability [43]. Since in humans it is possible to perform
only small arthroscopic sampling to evaluate the histo-
logical aspect of the regenerated tissue, deep histological
studies can be performed in vivo only in animal models.
To date few studies concerning cartilage regeneration
have been performed in animal models in vivo [44-52]
and, until recently, most of the research on stem cells has
been carried out in small laboratory animals [30,53-55].
However, these species do not represent an optimal model
for achieving cartilage regeneration in human. On the
contrary, the larger size and weight of adult sheep, which
place greater weight-bearing loads on the healing site, as
well as the structural, biochemical, physiological and im-
munological similarities to man and the ease and low costof their management with respect to other species, make
sheep an optimal experimental model for future clinical
applications in humans [50,56].
The stem origin of the in situ differentiated cells in the
regenerated tissue was confirmed by the FISH technique.
This experiment aims to evaluate if the treatment with
ES-like cells into osteochondral defects in the medial
femoral condyles of adult sheep can enhance the regen-
eration process of articular cartilage over a long time
period, without formation of teratomas.
Results
Only 17 animals were included in the statistical analysis,
because 5 sheep died from toxaemic gastroenteritis after
breaking through paddock fencing and freely consuming
grass covered with frost. One sheep belonging to the
24 month group died at about 12 months post-surgery,
and hence was included with the 12 month group. Ana-
lysis was thus performed on 2 sheep in the 1 month
group, 3 sheep each in the 2 and 6 month groups, 5
sheep in the 12 month group and 4 sheep in the 24 month
group.
Embryo sexing and ES-like cell characterization
Sexing PCR allowed selection of male embryos for produc-
tion of male ES-like cells. Male embryos showed 2 bands
corresponding to the sex-determining region Y-linked gene
(SRY) and the sheep SAT 1,114 DNA repeat unit (SAT) se-
quences, while female embryos showed only the band cor-
responding to the autosomal sequence SAT (Figure 1A).
ES-like colonies demonstrated their staminality state by
positive immunostaining for SSEAs monoclonal antibodies
(mAbs) and positive gene expression for Oct 4, Nanog, Sox
2 and Stat 3 genes (Figure 1B, C, D, E), and their undiffer-
entiated state by the absence of staining with any of the
anti-cytokeratin-18, Fe-C6, F1-652 and FORSE-1 mAbs.
Clinical assessment
Eight sheep were moderately lame in both hind limbs
the day after surgery, but they all walked normally by
day 9. No further problems with locomotion were noted
in any of the animals during the remainder of the study.
Macroscopic assessment
Since the interaction between time and treatment was
not significant for any of the analysed variables, it was re-
moved from the statistical model, to test the effect of the
main factors (treatment and time period). No significant
effect of treatment was observed in the macroscopic as-
sessment, either in the total or in the single category
scores throughout all considered time periods (from 1
to 24 months) (Table 1). However, ES samples showed
higher least square means with respect to empty defects
(ED) samples, both in the total macroscopic score, in
Figure 1 Embryo sex determination and ES-like colonies gene expression. A): Embryo sex determination. Lanes 1, 8, 9, 16: DNA marker
100–1000 bp ladder (Sigma); lane 2: negative control (no DNA); lane 3: female positive control (sheep oviductal cells); lane 4: male positive control
(male lamb fibroblasts); lanes 5, 10, 12, 13: female embryos; lanes 6, 7, 11, 14, 15: male embryos. B,C, D, E) ES-like colonies gene expression. B) Oct4gene
expression; C) Sox2 gene expression; D) Nanog gene expression; E) Stat3 gene expression. Lane 1: DNA Marker 100–1000 bp ladder (Sigma); lane 2:
negative control (no cDNA); lane 3: in vitro produced sheep blastocyst, used as positive control; lane 4: ES-like cells.
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while the integration of edges was slightly better in the
ED animals (Table 1). For sake of clarity in the presen-
tation of results, the interaction was maintained in the
statistical model in order to estimate the least square
means for each period per treatment level (Additional
file 1: Table S3).Evaluation at 1 month
The total macroscopic score showed better healing in the
ES samples than in the ED. The ES samples had a better
surface appearance and had greater filling with a soft, red
tissue (Figure 2A) than the ED samples (Table 1), where
only the bottom and the sides of the defect were coveredTable 1 Least square means ± standard error of ES and
ED macroscopic scores compared from 1 to 24 months
(17 ESM and 17 ED)
Categories Treatments
ES* ED† P value
Total macroscopic score 4.66 ± 0.4 3.81 ± 0.4 n.s.‡
Surface appearance 1.51 ± 0.2 1.06 ± 0.2 n.s.
Filling of defect 2.09 ± 0.2 1.65 ± 0.2 n.s.
Edges integration 1.06 ± 0.2 1.10 ± 0.2 n.s.
*Embryonic stem-like cells engrafted in the medial femoral condyle; †Empty
defect; ‡not significant.by the proliferating tissue (Figure 2E). Edge integration
was absent in all samples.
Evaluation at 2 months
The overall healing process decreased in the ES samples
with respect to the control group. Surface appearance
showed a flat whitish tissue with a regular and smooth
surface which completely filled the ES (Figure 2O), while
it only partially filled the ED (Figure 2I), despite the fact
that both treated and control groups showed the same
least square mean in both categories. In both samples the
newly proliferating tissue still lacked continuity with the
host cartilage, though the ED group showed a better least
square mean (Table 1).
Evaluation at 6 months
Both samples had opalescent-appearing regenerated tis-
sue with extended superficial cracks (Figure 2S and W),
showing the same least square means in the total macro-
scopic score and in the filling of the defect. ES samples
had slightly higher scores for surface appearance, and
slightly lower scores for edge integration (Table 1).
Evaluation at 12 months
Regenerated tissue, which appeared similar to pre-existing
cartilage, completely filled both defects, and was continu-
ous with the host tissue (Figure 3A and E). All examined
Figure 2 (See legend on next page.)
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Figure 2 Femur, sheep. Embryonic stem-like cells engraftment in the medial femoral condyle (ES) and empty defects (ED) at 1, 2 and 6 months
from surgery. A-D) ED at 1 month from surgery. E-H) ES at 1 months from surgery. I-L) ED at 2 months from surgery. M-P) ES at 2 months from
surgery. Q-T) ED at 6 months from surgery. U-X) ES at 6 months from surgery. A-E-I-M-Q-U) macroscopic appearance; B-J-N-R-V) histological
sections, Azan-Mallory staining. 2X magnification; bar: 1 mm. F) Haematoxylin-eosin staining, C-G-K-O-S-W) Safranine-O staining. D-H-L-P-T-X)
Collagen type II immunostaining.
Pilichi et al. BMC Veterinary Research  (2014) 10:301 Page 5 of 14categories showed higher least square means in ES sam-
ples with respect to the control group (Table 1).
Evaluation at 24 months
Both defects were completely filled by a newly formed
tissue, smooth and white like hyaline cartilage. Edges
were totally integrated with the host tissue, with the ex-
ception of one ED which showed a small fissure near
the edge (Figure 3I and O). Once again, all examined
categories showed higher least square means in ES sam-
ples with respect to the control group, and a slight over-
all decrease with respect to the 12 month time period
(Table 1).Figure 3 Femur, sheep. Embryonic stem-like cells engraftment in the me
from surgery. A-D) ED at 12 months from surgery. E-H) ES at 12 months fr
from surgery. A-E-I-M) macroscopic aspect; B-F-J-N) histological sections, Aza
staining. D-H-L-P) Collagen type II immunostaining.Histological assessment
As for the macroscopic assessment, the interaction be-
tween time and treatment was not significant for any of
the histological variables and was removed from the model
to test the effect of the main factors (treatment and time).
ES performed significantly better in the total histologi-
cal score (p < 0.001) and in the filling of defect, cartilage,
matrix, bone and edge categories (p < 0.05) with respect to
ED, while no significant differences were observed bet-
ween treated and control groups in degeneration or vascu-
larity (Table 2), though higher least square means were
reached by ES samples than control (Table 2). Once again,
to better clarify the evolution of the regeneration process,dial femoral condyle (ES) and empty defects (ED) at 12 and 24 months
om surgery. I-L) ED at 24 months from surgery. M-P) ES at 24 months
n-Mallory staining, 2X magnification; bar: 1 mm. C-G-K-O) Safranine-O
Table 2 Least square means ± standard error of
histological scores compared throughout all considered
periods
Categories Treatments P
valueES* ED†
total histological score 36.33 ± 1.1 30.41 ± 1.1 < 0.001
filling of defect 1.65 ± 0.1 1.22 ± 0.1 < 0.05
cartilage 6.75 ± 0.4 5.20 ± 0.4 < 0.05
matrix 5.83 ± 0.4 4.46 ± 0.4 < 0.05
bone 4.57 ± 0.2 3.90 ± 0.2 < 0.05
edges 1.81 ± 0.2 1.13 ± 0.2 < 0.05
degeneration 10.86 ± 0.2 10.61 ± 0.2 n.s.‡
vascularity 4.86 ± 0.5 3.89 ± 0.5 n.s.‡
*Embryonic stem-like cells engrafted in the left medial femoral condyle;
†Empty defect created in the right medial femoral condyle. ‡not significant.
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calculated (Additional file 1: Table S4).
Evaluation at 1 month
Proliferating granulation tissue rich in vessels and fibro-
blasts completely filled the cavity in the ES samples,
while it covered the bottom and the walls only of the ED
samples. Foci of endochondral ossification were detected
at the bottom of the ES samples; there was no integ-
ration between new and host tissue, despite their close
proximity. Regenerated tissue was negative for proteo-
glycans and collagen type II production in both groups
(Figure 2B, C, D and F, G, H). Higher least square means
were reached by ES samples with respect to controls in
the total histological score, filling of defect, cartilage, mat-
rix and degeneration categories, while they were equal in
both treated and control groups in bone and edges cat-
egories (Additional file 1: Table S4).
Evaluation at 2 months
ES were superficially filled by fibrous tissue and by sub-
chondral ossification at the bottom, while ED were less
completely filled and one sample showed a deep hole
covered by a thin bridge formed by the tangential layer.
Integration between new and host tissues was present
only at one edge in the ES. An initial production of pro-
teoglycans and a mild staining for collagen type II were
detectable at the bottom of both defects, while the fi-
brous tissue in the top was negative (Figure 2L, M, N
and P, Q, R). Higher least square means were reached by
ES samples with respect to controls in all the histological
categories (Additional file 1: Table S4).
Evaluation at 6 months
Both samples contained fibrocartilage in the superficial
part. There was woven bone with foci of subchondral
ossification at the bottom of the ED samples. Cartilageclefts and small subchondral cysts were sometimes pre-
sent. Clefts were deeper and localized at the edges with
surrounding degenerated matrix in the ED, in which
continuity between tangential layer proliferation and sub-
chondral ossification was sometimes interrupted. Proteo-
glycans were conspicuous in the ES, especially in the
deeper part of fibrocartilage, while an initial production
was detected within the foci of subchondral ossification
in the ED. A marked staining for collagen type II was
present in the regenerated tissue of both samples, to-
gether with some negative areas in the middle and dee-
per parts (Figure 2T, U, V and X, Y, Z). Higher least
square means were reached by ES samples with respect
to controls in the total histological score, matrix, bone
and edges categories, while they were equal in both ES
and ED groups in the filling of defect category, and slightly
lower in ES in respect to ED in the cartilage and degener-
ation categories (Additional file 1: Table S4).
Evaluation at 12 months
ES samples showed immature hyaline cartilage and lamel-
lar bone, and the ED group had immature hyaline cartilage
spaced out by fibrocartilage and woven bone, where con-
tinuity between tangential layer proliferation and subchon-
dral ossification was often absent, and only one edge was
integrated. ED samples sometimes showed deep cracks in-
volving the whole depth of the cartilage. Proteoglycan
staining was strong in the ES group and minimal in the
ED, while collagen type II immunostaining was intense in
both groups, with some negative areas in the centre of the
regenerated cartilage in the ED animals (Figure 3B, C, D
and F, G, H). Higher least square means were reached by
ES samples with respect to controls in all the histological
categories (Additional file 1: Table S4).
Evaluation at 24 months
The appearance of the newly formed tissue in ES ani-
mals was comparable to mature hyaline cartilage, lying
on a well-reconstituted subchondral plate formed by la-
mellar bone; integration between regenerated and host
tissue was present at both edges and mild to moderate
articular deterioration was seen (Figure 3P). The healed
cartilage consisted of a superficial zone with proliferat-
ing germinal cells and collagen fibres distributed paral-
lel to the articular surface, overwhelming an area rich
in chondrocytes organized in large clones, and a transi-
tional zone characterized by palisading chondrocytes and
spring-shaped arrangements of collagen fibres. Subjacent
to this was a radial zone with hypertrophic chondrocytes
and collagen fibres arranged perpendicular to the articular
surface, and a deep zone with calcification and formation
of tidemark, still discontinuous (Figure 3P and Figure 4A).
On the contrary, ED were filled by immature hyaline cartil-
age in the upper part and woven bone at the bottom,
Figure 4 Femur, sheep. Embryonic Stem-like cells engraftment at 24 months from surgery. A) Histological aspect: Azan-Mallory staining; 2×
magnification; bar: 500 μm. B) Fluorescent in situ hybridization (FISH): positive signals in chondrocytes derived from ES-like cells. 40× magnification; bar:
50 μm. C) Same field, 60× magnification; bar: 10 μm. D) Normal female adult articular cartilage from the right lateral femoral condyle (negative control).
No signals are detected within chondrocytes. 20× magnification; bar: 30 μm. E) Same field, 40× magnification; bar: 20 μm. F) Dot-Blot test with SRY probe.
K-: spot female sheep fibroblasts (negative control), K+: spot male sheep fibroblasts (positive control), 1–2: spot female ES-like cells, 3: spot male ES-like cells.
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tected (Figure 3L). Intense proteoglycan and collagen type
II staining was detected in the newly formed cartilage
(Figure 3M, N and Q, R). Higher least square means were
reached by ES samples with respect to the control group in
all the histological categories (Additional file 1: Table S4).
FISH detection
Dot-Blot showed positive spots with both DNA derived
from ES-like cell samples and male fibroblasts (positive
control), whereas female fibroblasts DNA (negative con-
trol) was negative, confirming the specificity of the chosen
probe (Figure 4A). FISH showed positive intranuclear sig-
nals only in the ES-like derived cells found in the newly
formed tissue at all-time points, while controls were al-
ways negative (Figure 4B, C, D, E).
Discussion
In this study ES showed significantly better histological
evidence of healing when compared to ED in most of
the examined categories. To our knowledge, this is the
first time that ES-like cells have been engrafted in sheep
and then evaluated out to 24 months post-surgery. Pre-
viously, engraftments had been assessed at a maximum
period of 18 months in sheep [4], 12 months in goats
[21], 8 months in horses [18] and 6 months in laboratory
animals [30,53-55].
Sheep have been shown to be a valid model for human
translational research when compared with laboratoryanimals, due to the increased stifle size, less effective na-
tive cartilage regeneration and longer lifespan. Moreover,
a recent study comparing the differences in geometry
and biomechanical properties of human, porcine, bovine
and ovine articular cartilage, found that human cartilage
had a significantly larger flexibility with respect to por-
cine and bovine cartilage, but not to ovine cartilage [57].
In addition, from the regulatory point of view, the ovine
model is one of the suggested large animal models for
pre-clinical studies [48]. However, in previous studies in
small ruminants (sheep [4,13,14,49,52] and goats [5,7,21]),
most animals were euthanized at 6 months, paralleling the
time frame of experiments in laboratory animals. Accor-
ding to the authors, this is insufficient time to observe
complete regeneration in large animals. Schneider-Wald
[58] states that the follow-up period for assessment of the
effectiveness of cartilage regeneration is 12 months. More-
over, in sheep, several authors [46,47,49-51] worked with
chondral defects, despite the fact that this type of defect
can’t heal spontaneously [1,2,6]. Most of the experiments
performed in sheep employed surgical techniques only
without the use of cells [4,13,52,59] and, even when stem
cells were used, the methods of delivery to the cartilage
varied from direct injection to implantation with a large
variety of scaffolds [60]. For these reasons, it is difficult to
compare results obtained in this experiment with previ-
ously reported trials.
Sexing PCR performed on trophoblastic cells lysed
during the immunosurgery procedure confirmed that
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sequence (SRY) as a marker for ES-like cells was effective
and reliable for this purpose [61]. To detect the stem ori-
gin of differentiated cells, several authors [21,49,62] em-
ploy green fluorescent protein (GFP) transduced cells.
However, this procedure is applicable only on cells that
can be expanded ex-vivo in large amounts, such as MSCs
[21,49] and rodent ESCs [62]. On the contrary, ungulate
embryonic stem cells show an early in vitro differentiation
[42,63], which does not allow production of the needed
amount of cells for the application of this technique. To
overcome this problem, the authors engrafted only male
ES-like cells in female sheep, and the SRY sequence was
used as a marker for the FISH technique, which allowed
to confirm the stem origin of differentiated cells.
ES-like colonies were positive for the SSEAs mAbs
and the gene expression for Oct 4, Nanog, Sox 2 and
Stat 3 genes, and negative for any of the mAbs marking
the differentiated state, demonstrating that the engrafted
cells were stem cells, in agreement with others [64-76].
The low number of ES-like cells engrafted was due to the
early in vitro differentiation of sheep ES-like cells, as men-
tioned above [42,63] which does not provide the higher
numbers of cells used in other studies [18,30,62]. This
forced us to use cells derived from the first passage, when
they were still in an undifferentiated state. The estab-
lishment of ES cell lines of domesticated ungulates is of
interest both for basic research, such as the study of
comparative embryology and the comprehension of the
mechanisms of cell biology related to stem cell main-
tenance and differentiation [42], and applied research,
such as the creation of models of human genetic dis-
eases and cell transplantation therapy [42].
The lateral para-patellar approach was shown to be
reproducible in a standardized fashion and reliable for
long-term success of the cell therapy. Indeed, all animals
walked normally 9 days after surgery and no signs of
major wound infection or limited range of motion were
detected, similar to previous reports in sheep [4,13,52],
goats [5,21] and rabbits [30,55] . Medial patellar disloca-
tion was necessary to reach the medial femoral condyle.
Lateral access guarantees greater resistance of the su-
tures in the various layers of the closure, thanks to the
presence of the fascia lata. Arthroscopy was not used be-
cause it did not allow the deposition of the cell-fibrin
graft in the defect. The surgeons noted that this tech-
nique was quite invasive and could have negatively influ-
enced the results, due to the loss of synovial fluid during
the surgical procedure and consequent dehydration of
articular cartilage. These problems have been overcome
in later studies (data not shown) with the introduction
of the mini-arthrotomy technique. Particular attention
has been paid to meticulously removing all calcified cartil-
age between the tidemark and the osteochondral junction,according to Hurtig [77]. This cartilage layer appears to
be an effective barrier to the invasion of the blood and
precursor cells from the subchondral bone, resulting in
a lack of attachment of the regenerated tissue to sub-
chondral bone [77].
No significant macroscopic differences were observed
between ES and ED samples. This is probably because of
the absence of the assessment of transverse sections,
perpendicular to the articular surface and about 1–2 cm
deep, which could have allowed evaluation of the quality
of the newly formed tissue deep in the samples, together
with the detection of subchondral cysts. In any case, this
experiment demonstrates that, in sheep, tissue resem-
bling cartilage appears only at 6 months post-surgery, as
noted by other authors [4,78], and integration of edges is
complete at 12 months, as reported by Akens [4] but in
contrast to the findings of Schleicher [78]. It is interes-
ting to note that at 24 months there was a slight overall
decrease in the regeneration process in both groups
(more marked in the ED group) as compared to 12 months.
The ES group performed significantly better in most
categories of histological assessment with respect to ED.
Beginning at the earliest time points, this group had more
normal architecture and a better quality of matrix in the
newly formed cartilage, similar to the findings of Akens
[4]. These findings suggest the enhancement of the phy-
siological regeneration process exerted by ES-like cells,
probably by means of paracrine signals [1,79]. Several
authors [8,17,19,80-83] outline the complex interplay
existing between proteoglycans and collagen type II, the
two most important components of the hyaline cartilage
matrix: the collagen fibrils serve to anchor the proteogly-
can matrix and contribute to resisting extrinsic forces dur-
ing loading and the intrinsic swelling that occurs within
the proteoglycan domain, while proteoglycans are respon-
sible for the generation of a hydrostatic pressure within
cartilage matrix, which allows it to counteract the loads
transmitted to it from the long bones during normal joint
articulation.
Tidemark appeared at 12 months after surgery, with-
out statistically significant differences between treatment
groups. It was still discontinuous in most of samples at
24 months post surgery, suggesting that the regenerative
process was not yet complete. The presence of the tide-
mark is an important finding: it has been reported that
this calcification front is in a state of dynamic equilib-
rium, where factors promoting mineralization are prob-
ably counterbalanced by substances that inhibit or limit
the extent of calcification, and this process of active calci-
fication and subsequent endochondral ossification seems
to be integral to the shape of the joint and, therefore, to
the distribution of load [84].
In relation to bone remodeling, lamellar bone was de-
tected 12 months after surgery in most of the ES
Table 3 Experimental design
Period-groups N° of sheep Stifle joint (medial
femoral condyle)
Treatment
1 month 4 Left ES*
Right ED†
2 months 4 Left ES
Right ED
6 months 4 Left ES
Right ED
12 months 4 Left ES
Right ED
24 months 6 Left ES
Right ED
22 44
*ES-like engraftment in the medial femoral condyle defect; †Empty Defect.
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This last finding is in contrast with Jackson [7] who, in
empty defects in goats at 13 months, found sclerotic
bone surrounding the defect adjacent to subchondral
areas, sparse bone resorption and marked endochondral
bone formation, probably because of the difference in
the anatomy and ambulation between sheep and goats.
These results further confirm the benefits that occurred
in the defects treated with ES-like engraftments, consid-
ering that a good remodeling of subchondral bone pro-
vides the right biomechanical support for the hydrostatic
compression in the cartilage, which is of critical import-
ance for the differentiation of hyaline cartilage [8,81].
ES samples showed very good integration between
the newly formed cartilage and the host tissue as com-
pared to ED samples, particularly evident at 12 and
24 months. These findings, similar to those reported
by Akens [4], seem likely to be predictive of the func-
tionality and durability of the regenerated tissue. It is
well known that the gap between implant and host
tissue is responsible for the initiation of cartilage de-
generation, as a result of a penetration of the synovial
fluid into the host-graft interface which results in re-
sorption within the subchondral bone area and cyst
formation [4,7,59].
Mild to moderate signs of articular deterioration (de-
lamination, fibrillation or clefts of the cartilage surface)
predominated in the ED samples. Subchondral bone cysts,
varying from mild to severe, were detected in both groups,
with a higher incidence at 6 months, similar to previously
published reports [4,7,59]. This could be due to the par-
ticular texture of the regenerated tissue at this time point,
enough hard to allow the penetrating synovial fluid to
reach high pressures but, at the same time, too soft to
counteract it, with consequent collapse of the walls and
enhancing of the cyst formation.
No signs of immune rejection or teratoma occurred in
any of the ES-like engraftments, despite the fact that en-
grafted animals were not immunosuppressed. It could be
due to the osteochondral microenvironment, which may
have forced the implanted cells to differentiate toward the
osteogenic and chondrogenic lineage [39-41,85] or to the
small number of cells implanted [16]. A recent study [62]
hypothesizes that cycling loading may affect the differenti-
ation of stem cells in osteochondral defects to the osteo-
cyte and chondrocyte phenotypes.
Conclusions
Heterologous embryonic stem-like cells implanted into
osteochondral defects in sheep femoral condyles enhanced
the regeneration of the articular hyaline cartilage, without
the occurrence of immune rejection or teratoma forma-
tion even at 24 months post-surgery. These findings are
encouraging for safe translation to human clinical trials.Methods
Ethics statement
The animals were maintained and treated in accord-
ance with Legislative Decree 116/92 guidelines based on
European Directive 86/609/EEC. Animal welfare was rou-
tinely checked by veterinarians from VTH (Veterinary
Teaching Hospital) of the Department of Veterinary
Medicine and every effort was made to minimize the
number of animals used and their suffering (see ARRIVE
checklist in Additional file 2). The experimental protocols
were approved by the Ethical Committee of the University
of Sassari and by the veterinary control officers of animal
protection in experimental and clinical studies conducted
at the University of Sassari (Auth. of 06/06/2012).
If not indicated otherwise, all chemicals were pur-
chased from Sigma-Aldrich.
Experimental design
Twenty-two Sarda ewes, about 5.5 years old and weighing
approximately 45 kg, without muscular-skeletal patholo-
gies, were used in this experiment. Sheep were divided
into 5 groups which were euthanized at 1, 2, 6, 12 and
24 month post-surgery, respectively. Each group was com-
posed of 4 sheep with the exception of the 24 month
group, where 6 sheep were allotted to account for possible
deaths during the study period. ES-like cells were en-
grafted in the osteochondral defect created in the left
medial femoral condyle (ES), while the identical defect
created in the controlateral stifle joint was left untreated
(ED) and served as a control. Thus, a total of 44 defects
were created: 22 ES and 22 ED (Table 3).
In vitro embryos production, embryo sexing, ES-like cell
production and characterization
About 100 embryos at the blastocyst stage were pro-
duced following in vitro maturation, fertilization, culture
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Since the presence of the SRY sequence was used as a
marker to detect male ES-like cells in the regenerated
tissue, only male embryos were selected to produce ES-
like cells, by means of a duplex PCR [61]: the 2 pairs of
primers (Life Technologies) identified both the SRY gene
sequence of male embryos (SRY-fwd 5′-CTCAGCAAAG
CACACCAGAC-3′, SRY-rev-5′-GAACTTTCAAGCAG
CTGAGGC-3′), and the SAT sequence in both sexes
(SAT-fwd 5′-TGGAAGCAAAGAACCCCGCT-3′, SAT-
rev 5′-TCGTGAGAAACCGCACACTG-3′). SAT was
used as positive control for the reaction. Male lamb fibro-
blasts and sheep oviductal cells were used as positive and
negative controls, respectively. Amplification products
were analysed on 2% agarose gel stained with ethidium
bromide and observed under ultraviolet light.
The inner cell mass (ICM) from each numerically
identified male embryo was isolated by immunosurgical
complement mediated lysis of trophoblastic cells and se-
parately cultured on a mouse fibroblast feeder layer for
5 to 6 days [65], to obtain ES-like colonies. These were
characterized both immunocytochemically, by detection
of surface antigens for staminality SSEA-1, SSEA-3 and
SSEA-4 (Developmental Studies Hybridoma Bank - DSHB,
University of Iowa, Iowa City, IA) [65] (Table 4) and by as-
sessment of the gene expression of Oct 4, Nanog, Sox 2
and Stat 3 genes [68]. To assess the absence of differenti-
ation towards germinal layers, cytokeratin, early meso-
derm, embryonic myosin and neural precursor cell specific
primary mAbs (DSHB) were used [65] (Table 4).
Preparation of cells for engraftment and surgical
procedures
For each graft, 2 to 3 male ES-like colonies were har-
vested from the Petri dish, disaggregated using trypsin
and pooled together, as previously described [16]. About
500,000 cells were embedded in 60 μl of fibrin glue and
engrafted into the cartilage defect.
All animals were given a general health examination,
dewormed and had their claws inspected prior to the ex-
perimental surgery. After sedation (Diazepam 0.4 mg/kg
IV) and sacro-coccigeal (S4-Co1) epidural anaesthesiaTable 4 Antibodies used for immunocytochemistry
Antigens Detected tissue I° Antibodies
SSEA-1 Staminality Marker Mc 480
SSEA-3 Staminality Marker Mc 631
SSEA-4 Staminality Marker Mc 813-70
Cytokeratin Endoderm Anti-cytokeratin peptide
Early mesoderm Early mesoderm Fe-C6
Embryonic myosin Late mesoderm F1-652
Neural precursor cells Ectoderm Forse-1(Lidocaine 2 mg/kg), the induction of the anaesthesia
was performed with Ketamine (3 mg/kg IV) and main-
tained with Ketamine (3 mg kg−1 h−1) and Fentanyl
(8 mcg kg−1 h−1). A lubricated stomach tube of 1 cm of
inner diameter was inserted into the rumen to prevent
bloating. The animal was positioned in dorsal recum-
bency in a cradle for thoracic containment, leaving pos-
terior limbs free. After disinfection and preparation of
the surgery field, with the knee placed in maximum
flexure, a para-patellar arthrotomy of both stifle joints
was performed using a lateral approach and medial pa-
tellar dislocation, to expose the articular surface of the
weight-bearing area of the medial femoral condyle. A
cranio-lateral cutaneous incision, of about 8 cm in length,
was performed over the rotula, followed by subcutaneous
tissue incision to visualize the septum between the super-
ficial lamina and the fascia lata and the biceps-femoral
muscle proximally and the retinaculum distally. Finally,
the incision of the articular capsule allowed access to the
joint. A full-thickness defect was made in the articular car-
tilage using a 6 mm diameter punch to mark off the edges
of the defect and to cut down into the cartilage until the
calcified portion was reached. A curettage was then per-
formed by using a little Williger spoon to remove cartilage
debris. To make the defect walls perfectly perpendicular
to the articular surface and to remove the whole calcified
layer of cartilage, a motorized drill for spinal surgery with
a stop-mechanism, so that the depth drilled was exactly
the same in all samples, was used. Thus, all defects had
the same diameter (6 mm) and depth (2 mm) and in-
volved the subchondral bone (osteochondral defects).
During drilling, the area was infused with saline solu-
tion to cool the tissue and to avoid dehydration of ar-
ticular cartilage due to the loss of synovial fluid during
the surgical procedure. Finally, an abrasion of the sub-
chondral bone plate was carried out using a 18 G needle,
to allow bleeding of the bottom of the defect and the con-
sequent access of both autologous mesenchymal stem
cells MSCs and growth factors from the underlying bone
marrow. The left joint received the ES-like cells embedded
in fibrin glue, while the right knee was left untreated to
serve as a control. All animals received an antibiotic andAntibodies dilution II° Antibodies
1:100 Anti-mouse IgMc
1:100 Anti-rat IgM (Pierce Thermo Scientific)
1:100 Anti-mouse IgG
18 1:100 Anti-mouse IgG
1:100 Anti-mouse IgM
1:100 Anti-mouse IgG
1:100 Anti-mouse IgM
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ketoprofen 2 mg/kg im) before the patella was reposi-
tioned and the wound sutured. All surgical procedures
were performed by the same operator, respecting animal
welfare laws. Antibiotic and antinflammatory therapy
(amoxicillin 40 mg/kg/day im and ketoprofen 2 mg/kg/
day im) was administered for 5 days. All animals were
kept confined in paddocks for 10 days in groups of 6
animals each, and then were allowed to roam freely on
pasture for the rest of the study.
Gross assessment
Immediately after euthanasia, the defects were photo-
graphed to allow the assessment by 2 blinded observers.
A semi-quantitative scoring system, developed by the
International Cartilage Repair Society (ICRS), (Additional
file 1: Table S1) was used and the values obtained were
averaged. Observations were initially recorded as per-
centages (surface appearance , filling of the defect, and
graft-host integration at the margins). These percent-
ages were converted to scores from 0–3 for purposes of
statistical analysis.
Histological and immunohistochemistry procedures and
evaluation
Samples containing regenerated tissue, adjacent host car-
tilage and subchondral bone (thickness: 0.5 cm; width:
2–3 cm; height: 1–2 cm; distance of cuts from edges of
defect: 0.2 cm) were harvested using a water-cooled cir-
cular saw. The tissue blocks were fixed in 10% neutral-
buffered formalin and then decalcified with a 1:1 citric
acid/formic acid solution for about 10 days. After wash-
ing in running tap water for 4–8 h to remove all traces
of decalcification solution, samples were routinely pro-
cessed for paraffin embedding. Three μm sections were
mounted on positively charged slides (Superfrost Plus,
Gerhard Menzel GmbH) to prevent detachment and
stained with hematoxylin-eosin for general tissue evalu-
ation, Azan-Mallory to demonstrate collagen fibres and
safranine-O to detect proteoglycans. All slides were pro-
cessed together to avoid variability. Immunohistochemis-
try was used to detect collagen type II in the cartilage
matrix. After deparaffinization, re-hydration, protease K
and Endo- and Tissue-Blocker (Biomeda) treatments, slide
were incubated overnight at 4°C with a primary anti-
body (anti-Collagen type II CIICI - DSHB) at 1:200 di-
lution, followed by the secondary biotinylated antibody
(Biomeda) for 10 min at room temperature (R.T.), and by
3% peroxidase solution for 10 min at RT. After staining with
diaminobenzidine (Biomeda) and counterstaining with hae-
matoxylin, slides were dehydrated, coverslipped, observed
under light microscopy and digital images were captured.
The lateral femoral condyle was used as positive (articular
cartilage) and negative (subchondral bone) controls.Two independent observers evaluated the regeneration
progress using a grading system developed by the authors
and derived from Caplan [87] (Additional file 1: Table S2)
and the 2 values obtained for each sample were averaged.
A total score of 5 indicated the worst possible healing,
while 56 indicated the best.
FISH technique
FISH assay was performed on one sample from each
period, as previously described [88], using the DNA probe
50 bp in length (biotin-5′AAAGGGAGGGAGAGAC-
CAAAGAAGTAGATGATGATGATGATGAAGTGATC
3′) built on the SRY sequence. To assess the effectiveness
of the probe, a membrane Dot-Blot test had been previ-
ously performed on the ES-like cell samples, using male
and female fibroblasts as positive and negative controls,
respectively. Sections mounted on positively charged slides
(Superfrost Plus, Gerhard Menzel GmbH), were deparaffi-
nised, rehydrated, permeabilized by 0.8% pepsin treatment
at 37°C for 30 min, post-fixed and incubated with a pre-
hybridization solution (50% hybridization solution, 43%
formamide and 7% double-distilled water) at 50°C for 2 h.
The probe (2000 ng/μl) was denatured at 98°C for 10 min
and immediately placed on ice. Tissue was denaturated at
98°C for 8 min with 200 μl of hybridization solution (50%
hybridization solution, 43% formamide, 1% probe and 6%
double-distilled water). Hybridization was performed at
50°C o/n in a humid chamber. After SSPE washings at de-
creasing concentration, endogenous phosphatases were
blocked by incubation with a blocking solution (500 μl of
2% BSA, 3 μl of 0.3% Triton X-100 , 500 μl of PBS) for
45 min at RT. The chromogen reaction was developed by
incubation with Extravidin-TRITC-conjugated for 2 h at
RT in the dark. Slides were counterstained with Hoechst,
mounted with an aqueous medium, coverslipped, sealed
with nail polish, observed under a fluorescent confocal
microscope and images recorded. All slides were proc-
essed together, including the right lateral femoral condyle
as a negative control.
Statistical analysis
An analysis of variance was performed on the macro-
scopic and histological data from the total as well as se-
lected category scores of both groups throughout all
time periods. The model of the analysis contained the
main effects of treatment and time from surgery and the
interaction between them, together with the random ef-
fect of the ewe within the period. The Mixed Procedure
of SAS 8.2 (SAS Institute Inc., Cary, NC, USA) was used
to perform the analysis.
Availability of supporting data
All the supporting data are included as additional files.
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Additional file 1: Provided with this submission, shows the
semi-quantitative macroscopic and histological scores for the
samples’ evaluation and the tables of least square means of
macroscopic and histological scores for each time period
(1, 2, 6, 12 and 24 months).
Additional file 2: ARRIVE checklist.
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